Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Generic drug savings by top drug in Canada's public drug plans 2012/2013

Total generic drug savings in Canadian public drug plans in 2012/2013, by top drug (in million Canadian dollars)*

by Statista Research Department, last edited Mar 31, 2015
Generic drug savings by top drug in Canada's public drug plans 2012/2013 This statistic depicts total generic drug savings in Canadian public drug plans in 2012/2013, by top drug. The total savings for Nabilone (Cesamet) in selected Canadian public drug plans amounted to 11.06 million Canadian dollars.
Show more

Total generic drug savings in Canadian public drug plans in 2012/2013, by top drug (in million Canadian dollars)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.